• Cy3-dCTP in Precision DNA Synthesis: Interface Engineering a

  2026-07-20

  Explore how Cyanine 3-deoxycytidine triphosphate (Cy3-dCTP) is revolutionizing direct enzymatic labeling of DNA and cDNA through interface engineering. Uncover advanced protocol strategies, scientific insights, and the practical implications for high-efficiency, multicolor fluorescence assays.

• Network Pharmacology Reveals SFI’s Anti-Glioma Mechanism via

  2026-07-19

  This study utilizes network pharmacology and experimental validation to determine that Shenqi Fuzheng injection (SFI) inhibits glioma cell proliferation and migration by targeting the SRC/PI3K/AKT signaling pathway. These findings clarify SFI’s molecular mechanism, highlighting its potential relevance for anti-angiogenic and tumor inhibition research in malignant gliomas.

• Entecavir for Chronic HBV in Decompensated Liver Disease: Re

  2026-07-18

  This review synthesizes the clinical pharmacology, efficacy, and tolerability of Entecavir (BMS200475) in the treatment of chronic hepatitis B virus infection among patients with decompensated liver disease. The findings inform both optimized therapeutic strategies and experimental protocols, providing robust evidence for Entecavir’s role in the most advanced clinical scenarios.

• Acetylation-Regulated Spliceosome Alters PARP Inhibitor Sens

  2026-07-17

  This study uncovers how acetylation-dependent regulation of the spliceosome core component SmD2 modulates alternative splicing, DNA repair gene expression, and sensitivity to PARP inhibitors in hepatocellular carcinoma (HCC). The findings reveal new therapeutic opportunities for targeting spliceosome dynamics and HDAC2 activity to enhance PARP inhibitor efficacy in HCC.

• Direct Programming of Fibroblasts to Thymic Epithelial Cells

  2026-07-17

  This study dissects the molecular mechanisms by which forced FOXN1 expression reprograms mouse embryonic fibroblasts into thymic epithelial cells (iTECs). The findings clarify Notch signaling's dual roles in TEC lineage specification and demonstrate how iTECs can be matured and functionally optimized, informing both basic thymus biology and potential translational applications.

• PPT (Propyl Pyrazole Triol): Dissecting ERα Biology in Lung

  2026-07-16

  Explore how PPT (Propyl Pyrazole Triol), a potent ERα agonist, enables precise investigation of estrogen receptor signaling and ceRNA networks in female lung adenocarcinoma. This article provides a unique integration of molecular mechanisms, protocol guidance, and translational insight for advanced cancer research.

• Moxifloxacin in Research: Mechanistic Depth and Assay Precis

  2026-07-16

  Explore how Moxifloxacin, a potent fluoroquinolone antibiotic, enables advanced research into DNA gyrase inhibition, cellular toxicity, and metabolic pathways. This article offers a mechanistic, evidence-driven perspective distinct from standard reviews.

• APEX2 Regulates TERT Expression in Human Embryonic Stem Cell

  2026-07-15

  The referenced study identifies apurinic/apyrimidinic endodeoxyribonuclease 2 (APEX2) as a crucial regulator of TERT gene expression in human embryonic stem cells (hESCs), a finding that links DNA repair machinery with telomerase regulation. These insights provide a new molecular target for modulating telomerase activity in stem cell biology and cancer research.

• ABT-263 (Navitoclax): Applied Apoptosis Workflows in Cancer

  2026-07-15

  ABT-263 (Navitoclax) transforms apoptosis research by enabling precision targeting of Bcl-2 family proteins in complex cancer models. This guide delivers actionable workflow enhancements, troubleshooting strategies, and real-world insights from the latest melanoma senolytic studies.

• ABT-263 (Navitoclax): Breaking Senescence Barriers in Cancer

  2026-07-14

  Explore the unique role of ABT-263 (Navitoclax) in targeting therapy-induced senescence and radio-resistant cancer cells. This article offers a deeper scientific perspective on apoptosis modulation and practical assay optimization, providing insights beyond traditional Bcl-2 inhibition.

• Mechanistic Mastery: HRP Goat Anti-Mouse IgG (H+L) in Transl

  2026-07-14

  This thought-leadership article decodes the mechanistic and strategic importance of deploying APExBIO’s affinity-purified, HRP-conjugated goat anti-mouse IgG (H+L) secondary antibody in translational cancer research. By integrating molecular insights from recent studies on KRASG12V-driven colorectal cancer, it offers actionable guidance for researchers striving to amplify immunodetection sensitivity and reproducibility, thereby bridging the gap between discovery and clinical application.

• Mitochondrial Dysfunction and MnTBAP Rescue in Chronic Stres

  2026-07-13

  This study demonstrates that chronic unpredictable mild stress (CUMS) induces depression-like behavior in rats via brain mitochondrial dysfunction and neuroinflammation. Mitochondria-targeted antioxidant MnTBAP alleviates both behavioral and molecular effects, highlighting redox modulation as a mechanistic link in stress-induced depression.

• Thrombin B Chain: Advancing Translational Coagulation Models

  2026-07-13

  This article provides translational researchers with mechanistic insight and strategic guidance for leveraging Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] in vascular biology, hemostasis, and fibrin matrix modeling. Integrating the latest evidence, it highlights APExBIO’s ultra-pure reagent, competitive landscape analysis, and protocol optimization—helping researchers build more predictive and reproducible experimental models.

• Protease Inhibitor Cocktail EDTA-Free: Enhancing Protein Int

  2026-07-12

  Unlock reproducible protein extraction and phosphorylation studies with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). This advanced formulation empowers researchers to protect labile proteins, especially in workflows demanding divalent cation compatibility or sensitive signaling analysis.

• Exosomal SNORD52 Promotes M2 Macrophage Polarization via JAK

  2026-07-10

  This study uncovers a key role for exosomal SNORD52 in driving M2 macrophage polarization through activation of the JAK2/STAT6 pathway in hepatocellular carcinoma (HCC). The findings highlight a novel exosome-mediated mechanism of tumor immune modulation, opening new avenues for targeted cancer research and therapeutic intervention.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page